Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
2020-01-01 Moris, L.; Cumberbatch, M. G.; Van den Broeck, T.; Gandaglia, G.; Fossati, N.; Kelly, B.; Pal, R.; Briers, E.; Cornford, P.; De Santis, M.; Fanti, S.; Gillessen, S.; Grummet, J. P.; Henry, A. M.; Lam, T. B. L.; Lardas, M.; Liew, M.; Mason, M. D.; Omar, M. I.; Rouviere, O.; Schoots, I. G.; Tilki, D.; van den Bergh, R. C. N.; van Der Kwast, T. H.; van Der Poel, H. G.; Willemse, P. -P. M.; Yuan, C. Y.; Konety, B.; Dorff, T.; Jain, S.; Mottet, N.; Wiegel, T.
Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review
2021-01-01 Kretschmer, A.; Ploussard, G.; Heidegger, I.; Tsaur, I.; Borgmann, H.; Surcel, C.; Mathieu, R.; de Visschere, P.; Valerio, M.; van den Bergh, R. C. N.; Marra, G.; Thibault, C.; Ost, P.; Gandaglia, G.; Tilki, D.
Hereditary prostate cancer – Primetime for genetic testing?
2019-01-01 Heidegger, I.; Tsaur, I.; Borgmann, H.; Surcel, C.; Kretschmer, A.; Mathieu, R.; Visschere, P. D.; Valerio, M.; van den Bergh, R. C. N.; Ost, P.; Tilki, D.; Gandaglia, G.; Ploussard, G.
Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based study
2014-01-01 Larouche, A.; Becker, A.; Schiffmann, J.; Roghmann, F.; Gandaglia, G.; Hanna, N.; Tian, Z.; Perrotte, P.; Schlomm, T.; Graefen, M.; Ahyai, S.; Trinh, Q. -D.; Karakiewicz, P. I.; Sun, M.
Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapy
2014-01-01 Hansen, J.; Gandaglia, G.; Bianchi, M.; Sun, M.; Rink, M.; Tian, Z.; Meskawi, M.; Trinh, Q. -D.; Shariat, S. F.; Perrotte, P.; Chun, F. K. -H.; Graefen, M.; Karakiewicz, P. I.
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration
2022-01-01 Lonati, Chiara; Baumeister, Philipp; Afferi, Luca; Mari, Andrea; Minervini, Andrea; Krajewski, Wojciech; Azizi, Sosan; Hendricksen, Kees; Martini, Alberto; Necchi, Andrea; Montorsi, Francesco; Briganti, Alberto; Colombo, Renzo; Tafuri, Alessandro; Antonelli, Alessandro; Cerruto, Maria Angela; Rouprêt, Morgan; Masson-Lecomte, Alexandra; Laukhtina, Ekaterina; D'Andrea, David; Shariat, Shahrokh F; Soria, Francesco; Marra, Giancarlo; Gontero, Paolo; Contieri, Roberto; Hurle, Rodolfo; Valiquette, Anne Sophie; Mir, M Carmen; Zamboni, Stefania; Simeone, Claudio; Klatte, Tobias; Teoh, Jeremy Yuen-Chun; Yoshida, Soichiro; Fujii, Yasuhisa; Carando, Roberto; Schulz, Gerald B; Mordasini, Livio; Mattei, Agostino; Moschini, Marco
Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities
2022-01-01 Mir, M Carmen; Campi, Riccardo; Loriot, Yohann; Puente, Javier; Giannarini, Gianluca; Necchi, Andrea; Rouprêt, Morgan
Clinically advanced pheochromocytomas and paragangliomas: A comprehensive genomic profiling study
2021-01-01 Bratslavsky, G.; Sokol, E. S.; Daneshvar, M.; Necchi, A.; Shapiro, O.; Jacob, J.; Liu, N.; Sanford, T. S.; Pinkhasov, R.; Goldberg, H.; Killian, J. K.; Ramkissoon, S.; Severson, E. A.; Huang, R. S. P.; Danziger, N.; Mollapour, M.; Ross, J. S.; Pacak, K.
Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial
2020-01-01 Drakaki, A.; Kirby, C. J.; Van Der Heijden, M. S.; Petrylak, D. P.; Powles, T.; Chi, K. N.; Flechon, A.; Necchi, A.; Geczi, L.; Lee, J. -L.; Gakis, G.; Bracarda, S.; Chowdhury, S.; Lin, C. -C.; Keizman, D.; Vaishampayan, U. N.; Zimmermann, A. H.; Bell-Mcguinn, K.; Castellano, D.
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab?
2021-01-01 Pederzoli, F.; Bandini, M.; Raggi, D.; Marandino, L.; Basile, G.; Alfano, M.; Colombo, R.; Salonia, A.; Briganti, A.; Gallina, A.; Montorsi, F.; Necchi, A.
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial
2021-01-01 Marandino, L.; Raggi, D.; Calareso, G.; Alessi, A.; Colecchia, M.; Martini, A.; Briganti, A.; Montorsi, F.; Madison, R.; Ross, J. S.; Necchi, A.
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer
2021-01-01 Necchi, A.; Cucchiara, V.; Grivas, P.; Bratslavsky, G.; Jacob, J.; Spiess, P. E.; Sokol, E. S.; Killian, J. K.; Lin, D.; Ramkissoon, S.; Huang, R. S. P.; Madison, R. W.; Venstrom, J. M.; Schrock, A. B.; Danziger, N.; Decker, B.; Gjoerup, O.; Graf, R. P.; Oxnard, G. R.; Tukachinsky, H.; Ross, J. S.
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
2020-01-01 Dobe, T. -R.; Califano, G.; von Rundstedt, F. -C.; Ouzaid, I.; Albisinni, S.; Aziz, A.; Di Trapani, E.; Hendricksen, K.; Krajewski, W.; Mari, A.; Moschini, M.; Necchi, A.; Noon, A. P.; Poyet, C.; Pradere, B.; Rink, M.; Roghmann, F.; Sargos, P.; Seiler, R.; Soria, F.; Vetterlein, M. W.; Xylinas, E.
Survival and new prognosticators in metastatic seminoma: Results from the IGCCCG-update consortium
2021-01-01 Beyer, J.; Collette, L.; Sauve, N.; Daugaard, G.; Feldman, D. R.; Tandstad, T.; Tryakin, A.; Stahl, O.; Gonzalez-Billalabeitia, E.; de Giorgi, U.; Culine, S.; de Wit, R.; Hansen, A. R.; Bebek, M.; Terbuch, A.; Albany, C.; Hentrich, M.; Gietema, J. A.; Negaard, H.; Huddart, R. A.; Lorch, A.; Cafferty, F. H.; Heng, D. Y. C.; Sweeney, C. J.; Winquist, E.; Chovanec, M.; Fankhauser, C.; Stark, D.; Grimison, P.; Necchi, A.; Tran, B.; Heidenreich, A.; Shamash, J.; Sternberg, C. N.; Vaughn, D. J.; Duran, I.; Bokemeyer, C.; Patrikidou, A.; Cathomas, R.; Assele, S.; Gillessen, S.
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
2021-01-01 Bersanelli, M.; Buti, S.; Cortellini, A.; Bandini, M.; Banna, G. L.; Pederzoli, F.; Fare, E.; Raggi, D.; Giannatempo, P.; De Giorgi, U.; Basso, U.; Losanno, T.; Santini, D.; Mucciarini, C.; Tucci, M.; Tambaro, R.; Farnesi, A.; Caffo, O.; Veccia, A.; Naglieri, E.; Briganti, A.; Procopio, G.; Pignata, S.; Necchi, A.
Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes
2020-01-01 Voskuilen, C. S.; Seiler, R.; Rink, M.; Poyet, C.; Noon, A. P.; Roghmann, F.; Necchi, A.; Aziz, A.; Lavolle, A.; Young, M. J.; Marks, P.; Saba, K.; van Rhijn, B. W. G.; Fransen van de Putte, E. E.; Ablat, J.; Black, P. C.; Sosnowski, R.; Dobruch, J.; Kumar, P.; Jallad, S.; Catto, J. W. F.; Xylinas, E.; Hendricksen, K.
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
2020-01-01 Necchi, A.; Nishiyama, H.; Matsubara, N.; Lee, J. -L.; Petrylak, D. P.; de Wit, R.; Drakaki, A.; Liepa, A. M.; Mao, H.; Bell-McGuinn, K.; Powles, T.
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review
2021-01-01 Chakiryan, N. H.; Dahmen, A.; Cucchiara, V.; Briganti, A.; Montorsi, F.; Salonia, A.; Spiess, P. E.; Necchi, A.
Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium
2021-01-01 Gillessen, S.; Sauve, N.; Collette, L.; Daugaard, G.; de Wit, R.; Albany, C.; Tryakin, A.; Fizazi, K.; Stahl, O.; Gietema, J. A.; de Giorgi, U.; Cafferty, F. H.; Hansen, A. R.; Tandstad, T.; Huddart, R. A.; Necchi, A.; Sweeney, C. J.; Garcia-Del-Muro, X.; Heng, D. Y. C.; Lorch, A.; Chovanec, M.; Winquist, E.; Grimison, P.; Feldman, D. R.; Terbuch, A.; Hentrich, M.; Bokemeyer, C.; Negaard, H.; Fankhauser, C.; Shamash, J.; Vaughn, D. J.; Sternberg, C. N.; Heidenreich, A.; Beyer, J.
Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE-01 study
2021-01-01 Trevisani, F.; Di Marco, F.; Raggi, D.; Bettiga, A.; Vago, R.; Larcher, A.; Cinque, A.; Salonia, A.; Briganti, A.; Capitanio, U.; Necchi, A.; Montorsi, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review | 1-gen-2020 | Moris, L.; Cumberbatch, M. G.; Van den Broeck, T.; Gandaglia, G.; Fossati, N.; Kelly, B.; Pal, R.; Briers, E.; Cornford, P.; De Santis, M.; Fanti, S.; Gillessen, S.; Grummet, J. P.; Henry, A. M.; Lam, T. B. L.; Lardas, M.; Liew, M.; Mason, M. D.; Omar, M. I.; Rouviere, O.; Schoots, I. G.; Tilki, D.; van den Bergh, R. C. N.; van Der Kwast, T. H.; van Der Poel, H. G.; Willemse, P. -P. M.; Yuan, C. Y.; Konety, B.; Dorff, T.; Jain, S.; Mottet, N.; Wiegel, T. | |
| Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review | 1-gen-2021 | Kretschmer, A.; Ploussard, G.; Heidegger, I.; Tsaur, I.; Borgmann, H.; Surcel, C.; Mathieu, R.; de Visschere, P.; Valerio, M.; van den Bergh, R. C. N.; Marra, G.; Thibault, C.; Ost, P.; Gandaglia, G.; Tilki, D. | |
| Hereditary prostate cancer – Primetime for genetic testing? | 1-gen-2019 | Heidegger, I.; Tsaur, I.; Borgmann, H.; Surcel, C.; Kretschmer, A.; Mathieu, R.; Visschere, P. D.; Valerio, M.; van den Bergh, R. C. N.; Ost, P.; Tilki, D.; Gandaglia, G.; Ploussard, G. | |
| Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based study | 1-gen-2014 | Larouche, A.; Becker, A.; Schiffmann, J.; Roghmann, F.; Gandaglia, G.; Hanna, N.; Tian, Z.; Perrotte, P.; Schlomm, T.; Graefen, M.; Ahyai, S.; Trinh, Q. -D.; Karakiewicz, P. I.; Sun, M. | |
| Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapy | 1-gen-2014 | Hansen, J.; Gandaglia, G.; Bianchi, M.; Sun, M.; Rink, M.; Tian, Z.; Meskawi, M.; Trinh, Q. -D.; Shariat, S. F.; Perrotte, P.; Chun, F. K. -H.; Graefen, M.; Karakiewicz, P. I. | |
| Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration | 1-gen-2022 | Lonati, Chiara; Baumeister, Philipp; Afferi, Luca; Mari, Andrea; Minervini, Andrea; Krajewski, Wojciech; Azizi, Sosan; Hendricksen, Kees; Martini, Alberto; Necchi, Andrea; Montorsi, Francesco; Briganti, Alberto; Colombo, Renzo; Tafuri, Alessandro; Antonelli, Alessandro; Cerruto, Maria Angela; Rouprêt, Morgan; Masson-Lecomte, Alexandra; Laukhtina, Ekaterina; D'Andrea, David; Shariat, Shahrokh F; Soria, Francesco; Marra, Giancarlo; Gontero, Paolo; Contieri, Roberto; Hurle, Rodolfo; Valiquette, Anne Sophie; Mir, M Carmen; Zamboni, Stefania; Simeone, Claudio; Klatte, Tobias; Teoh, Jeremy Yuen-Chun; Yoshida, Soichiro; Fujii, Yasuhisa; Carando, Roberto; Schulz, Gerald B; Mordasini, Livio; Mattei, Agostino; Moschini, Marco | |
| Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities | 1-gen-2022 | Mir, M Carmen; Campi, Riccardo; Loriot, Yohann; Puente, Javier; Giannarini, Gianluca; Necchi, Andrea; Rouprêt, Morgan | |
| Clinically advanced pheochromocytomas and paragangliomas: A comprehensive genomic profiling study | 1-gen-2021 | Bratslavsky, G.; Sokol, E. S.; Daneshvar, M.; Necchi, A.; Shapiro, O.; Jacob, J.; Liu, N.; Sanford, T. S.; Pinkhasov, R.; Goldberg, H.; Killian, J. K.; Ramkissoon, S.; Severson, E. A.; Huang, R. S. P.; Danziger, N.; Mollapour, M.; Ross, J. S.; Pacak, K. | |
| Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial | 1-gen-2020 | Drakaki, A.; Kirby, C. J.; Van Der Heijden, M. S.; Petrylak, D. P.; Powles, T.; Chi, K. N.; Flechon, A.; Necchi, A.; Geczi, L.; Lee, J. -L.; Gakis, G.; Bracarda, S.; Chowdhury, S.; Lin, C. -C.; Keizman, D.; Vaishampayan, U. N.; Zimmermann, A. H.; Bell-Mcguinn, K.; Castellano, D. | |
| Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? | 1-gen-2021 | Pederzoli, F.; Bandini, M.; Raggi, D.; Marandino, L.; Basile, G.; Alfano, M.; Colombo, R.; Salonia, A.; Briganti, A.; Gallina, A.; Montorsi, F.; Necchi, A. | |
| Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial | 1-gen-2021 | Marandino, L.; Raggi, D.; Calareso, G.; Alessi, A.; Colecchia, M.; Martini, A.; Briganti, A.; Montorsi, F.; Madison, R.; Ross, J. S.; Necchi, A. | |
| Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer | 1-gen-2021 | Necchi, A.; Cucchiara, V.; Grivas, P.; Bratslavsky, G.; Jacob, J.; Spiess, P. E.; Sokol, E. S.; Killian, J. K.; Lin, D.; Ramkissoon, S.; Huang, R. S. P.; Madison, R. W.; Venstrom, J. M.; Schrock, A. B.; Danziger, N.; Decker, B.; Gjoerup, O.; Graf, R. P.; Oxnard, G. R.; Tukachinsky, H.; Ross, J. S. | |
| Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group | 1-gen-2020 | Dobe, T. -R.; Califano, G.; von Rundstedt, F. -C.; Ouzaid, I.; Albisinni, S.; Aziz, A.; Di Trapani, E.; Hendricksen, K.; Krajewski, W.; Mari, A.; Moschini, M.; Necchi, A.; Noon, A. P.; Poyet, C.; Pradere, B.; Rink, M.; Roghmann, F.; Sargos, P.; Seiler, R.; Soria, F.; Vetterlein, M. W.; Xylinas, E. | |
| Survival and new prognosticators in metastatic seminoma: Results from the IGCCCG-update consortium | 1-gen-2021 | Beyer, J.; Collette, L.; Sauve, N.; Daugaard, G.; Feldman, D. R.; Tandstad, T.; Tryakin, A.; Stahl, O.; Gonzalez-Billalabeitia, E.; de Giorgi, U.; Culine, S.; de Wit, R.; Hansen, A. R.; Bebek, M.; Terbuch, A.; Albany, C.; Hentrich, M.; Gietema, J. A.; Negaard, H.; Huddart, R. A.; Lorch, A.; Cafferty, F. H.; Heng, D. Y. C.; Sweeney, C. J.; Winquist, E.; Chovanec, M.; Fankhauser, C.; Stark, D.; Grimison, P.; Necchi, A.; Tran, B.; Heidenreich, A.; Shamash, J.; Sternberg, C. N.; Vaughn, D. J.; Duran, I.; Bokemeyer, C.; Patrikidou, A.; Cathomas, R.; Assele, S.; Gillessen, S. | |
| Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) | 1-gen-2021 | Bersanelli, M.; Buti, S.; Cortellini, A.; Bandini, M.; Banna, G. L.; Pederzoli, F.; Fare, E.; Raggi, D.; Giannatempo, P.; De Giorgi, U.; Basso, U.; Losanno, T.; Santini, D.; Mucciarini, C.; Tucci, M.; Tambaro, R.; Farnesi, A.; Caffo, O.; Veccia, A.; Naglieri, E.; Briganti, A.; Procopio, G.; Pignata, S.; Necchi, A. | |
| Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes | 1-gen-2020 | Voskuilen, C. S.; Seiler, R.; Rink, M.; Poyet, C.; Noon, A. P.; Roghmann, F.; Necchi, A.; Aziz, A.; Lavolle, A.; Young, M. J.; Marks, P.; Saba, K.; van Rhijn, B. W. G.; Fransen van de Putte, E. E.; Ablat, J.; Black, P. C.; Sosnowski, R.; Dobruch, J.; Kumar, P.; Jallad, S.; Catto, J. W. F.; Xylinas, E.; Hendricksen, K. | |
| Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE) | 1-gen-2020 | Necchi, A.; Nishiyama, H.; Matsubara, N.; Lee, J. -L.; Petrylak, D. P.; de Wit, R.; Drakaki, A.; Liepa, A. M.; Mao, H.; Bell-McGuinn, K.; Powles, T. | |
| Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review | 1-gen-2021 | Chakiryan, N. H.; Dahmen, A.; Cucchiara, V.; Briganti, A.; Montorsi, F.; Salonia, A.; Spiess, P. E.; Necchi, A. | |
| Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium | 1-gen-2021 | Gillessen, S.; Sauve, N.; Collette, L.; Daugaard, G.; de Wit, R.; Albany, C.; Tryakin, A.; Fizazi, K.; Stahl, O.; Gietema, J. A.; de Giorgi, U.; Cafferty, F. H.; Hansen, A. R.; Tandstad, T.; Huddart, R. A.; Necchi, A.; Sweeney, C. J.; Garcia-Del-Muro, X.; Heng, D. Y. C.; Lorch, A.; Chovanec, M.; Winquist, E.; Grimison, P.; Feldman, D. R.; Terbuch, A.; Hentrich, M.; Bokemeyer, C.; Negaard, H.; Fankhauser, C.; Shamash, J.; Vaughn, D. J.; Sternberg, C. N.; Heidenreich, A.; Beyer, J. | |
| Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE-01 study | 1-gen-2021 | Trevisani, F.; Di Marco, F.; Raggi, D.; Bettiga, A.; Vago, R.; Larcher, A.; Cinque, A.; Salonia, A.; Briganti, A.; Capitanio, U.; Necchi, A.; Montorsi, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40134
Data di pubblicazione
- In corso di stampa9
- 2020 - 202712186
- 2010 - 201915980
- 2000 - 20097460
- 1990 - 19993486
- 1980 - 1989935
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.823
- Elsevier B.V.809
- Springer Science and Business Med...552
- John Wiley and Sons Inc549
- Oxford University Press506
- Lippincott Williams and Wilkins435
- Springer374
- Elsevier Ltd350
- MDPI348
- Springer Nature296
Rivista
- EUROPEAN UROLOGY535
- BLOOD372
- PLOS ONE313
- JOURNAL OF NEUROLOGY291
- EUROPEAN JOURNAL OF HEART FAILURE281
- NEUROLOGY270
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL225
- MULTIPLE SCLEROSIS219
- SCIENTIFIC REPORTS215
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19636
- Retrospective Studies628
- Treatment Outcome603
- Prognosis483
Lingua
- eng29490
- ita1971
- fre65
- und55
- spa34
- ger26
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext32003
- reserved4297
- open3722
- partially open104
- embargoed7
- mixed1